Les entreprises US utiliseraient mal la "competitive intelligence"
C'est ce qui ressort d'une étude effectuée par le cabinet Outward Insights.
Quelques éléments de l'étude:
- Almost two-fifths (38%) of respondents feel that CI does "not have sufficient stature" in their organizations to have a "significant impact," including 30% of those from companies with revenues of more than $1 billion.
- Additional problems respondents believe hampers the success of CI in their respective companies includes:
- Insufficient funding - 43%
- Internal bureaucracy - 41%
- Intelligence team lacks sufficient clout - 28%
- Executives do not recognize value of intelligence - 20%
- Just 27% of hi-tech respondents said they integrated competitor reaction into their new product planning while insurance (72%) and pharmaceutical (65%) respondents rely on it much more.
- Overall, financial services companies were less likely to have organized intelligence (61% vs. 71% norm) and less likely to make intelligence an integral part of their strategic planning process (78% vs. 85% norm) versus insurance, pharma and hi-tech companies.
Articles portant sur des thèmes similaires :
- Lu pour vous : Petite histoire de l'intelligence économique, par Nicolas Moinet - 26/11/10
- Le lancement du portail de l'IE c'est aujourd'hui! - 11/05/10
- Iceberg IE n°3 : du 01/03/2009 au 21/03/2009 (14 items) - 21/03/09
- Un livre audio gratuit sur l'intelligence économique par Henri Dou - 02/01/09
- Consultez le rapport d'Airbus sur les problèmes du Boeing 787. - 06/12/08









Lien croisé
Ecrit par Anonyme, le Mercredi 1 Mars 2006, 18:47
intelligence economique - Sujets chauds : "OF - Les entreprises US utiliseraient mal la "competitive intelligence""
Lien croisé
Ecrit par Anonyme, le Mardi 11 Avril 2006, 01:21
Outils Froids => : "1%Intelligence team lacks sufficient clout - 28%Executives do not recognize value of intelligence - 20%Just 27% of hi-tech respondents said they integrated competitor reaction into their new product planning while insurance (72%) and pharmaceutical (65%) respondents rely on it much more.Overall, financial services companies were less likely...[http://www.outilsfroids.net/news/883.shtml] "